Brain+ A/S (CPH:BRAINP)
Denmark
· Delayed Price · Currency is DKK 0.0032
+0.0004 (14.29%)
Mar 9, 2026, 4:14 PM CET
Brain+ Market Cap
Brain+ has a market cap or net worth of 3.17 million as of March 9, 2026. Its market cap has decreased by -75.29% in one year.
Market Cap
3.17M
Enterprise Value
-1.17M
Revenue
5.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since October 7, 2021, Brain+'s market cap has decreased from 51.99M to 3.17M, a decrease of -93.90%. That is a compound annual growth rate of -46.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.17M | -72.00% |
| Dec 30, 2025 | 11.33M | -43.17% |
| Dec 30, 2024 | 19.94M | 56.98% |
| Dec 29, 2023 | 12.70M | -37.15% |
| Dec 30, 2022 | 20.21M | -50.00% |
| Dec 30, 2021 | 40.41M | -22.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,101.56B |
| Genmab | 106.28B |
| Coloplast | 103.91B |
| ALK-Abelló | 49.32B |
| BioPorto | 450.54M |
| Pharma Equity Group | 116.37M |
| ViroGates | 111.38M |
| Scandinavian Medical Solutions | 97.04M |